✦ LIBER ✦

The gastrointestinal tolerability of a novel COX-2 selective inhibitor, lumiracoxb, in osteoarthritis patients: Pooled analysis

✍ Scribed by Hawkey, Christopher J.; Gitton, Xavier; Gimona, Alberto; Hoexter, Godehard; Weinstein, Wilfred M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of the small intestinal toler

✍ Jeremy A. Tibble; Gudmunder Sigthorsson; Ingvar Bjarnason 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Upper gastrointestinal (UGI) tolerabilit

✍ Goldstein, Jay L.; Eisen, Glenn M.; Hanna, David B.; Burke, Thomas 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 456 KB

The effects of COX-2 specific inhibitors

✍ Joseph A. Puma; Alfonso E. Bello; Jennifer J. Rodriguez; John G. Fort 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 50 KB

Antihypertensive efficacy, safety, and t

✍ Matthew R. Weir; Christopher Bush; David R. Anderson; Jack Zhang; Deborah Keefe; 📂 Article 📅 2007 🏛 Elsevier 🌐 English ⚖ 1017 KB

COX-2-selective inhibitors and the risk

✍ B. Nørgård; L. Pedersen; S. P. Johnsen; R. E. Tarone; J. K. McLaughlin; S. Friis 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Selective COX-2 inhibitor versus nonsele

✍ Deting Xue; Qiang Zheng; Hang Li; Shengjun Qian; Bo Zhang; Zhijun Pan 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 169 KB